Development of the coronavirus disease 2019 (COVID-19) vaccine has been key to countering the pandemic caused by severe acute ...
AstraZeneca PLC aims for $80 billion revenue by 2030 through strong growth in oncology, biopharmaceuticals, and rare diseases ...
Four years after winning an FDA approval for Koselugo to treat children with the rare disorder neurofibromatosis type 1 (NF1) ...
AstraZeneca has paused its planned £450 million investment in the UK for vaccine R&D as it continues discussions with the ...
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
TEZSPIRE demonstrated a statistically significant and clinically meaningful reduction in nasal polyp size and reduced nasal congestion compared to placebo ...
Covid vaccines left Aussie mother-of-two Ellie Sutton in such agony she 'prayed for death' and has considered euthanasia.
In a historic health milestone, Sudan has launched its first malaria vaccination campaign amid 18 months of civil conflict, aiming to protect thousands of children from the deadly disease. Sourced fro ...
AstraZeneca said its experimental weight loss pill was well tolerated by patients in an early-stage clinical trial. The Anglo ...
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-Mâ„¢ adjuvant, today announced that Åsa ...
The long-awaited final phase of a UN-supported polio vaccine campaign began on Saturday in bombarded, besieged northern Gaza even as reports emerged that one vaccination centre had been hit during a ...
AstraZeneca’s China president is under investigation in ... many in China’s expat business community have grown alarmed over ...